Research ArticleArticle

Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis

MIKE J.L. PETERS, IZHAR C. van EIJK, YVO M. SMULDERS, ERIK SERNE, BEN A.C. DIJKMANS, IRENE E. van der HORST-BRUINSMA and MICHAEL T. NURMOHAMED
The Journal of Rheumatology January 2010, 37 (1) 161-166; DOI: https://doi.org/10.3899/jrheum.090667

REFERENCES

  1. 1.↵
    1. Braun J,
    2. Bollow M,
    3. Remlinger G,
    4. Eggens U,
    5. Rudwaleit M,
    6. Distler A,
    7. et al.
    Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58–67.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Lautermann D,
    2. Braun J
    . Ankylosing spondylitis — cardiac manifestations. Clin Exp Rheumatol 2002;20 Suppl:S11–S15.
    OpenUrlPubMed
  3. 3.↵
    1. Lehtinen K
    . Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174–6.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Peters MJ,
    2. van der Horst-Bruinsma IE,
    3. Dijkmans BA,
    4. Nurmohamed MT
    . Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585–92.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Peters MJ,
    2. Visman I,
    3. Nielen MM,
    4. van Dillen N,
    5. Verheij RA,
    6. van der Horst-Bruinsma IE,
    7. et al.
    Ankylosing spondylitis; a risk factor for myocardial infarction. Ann Rheum Dis 2009 Apr 28. [Epub ahead of print]
  6. 6.↵
    1. van Halm VP,
    2. van Denderen JC,
    3. Peters MJ,
    4. Twisk JW,
    5. van der PM,
    6. van der Horst-Bruinsma IE,
    7. et al.
    Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 2006;65:1473–7.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Divecha H,
    2. Sattar N,
    3. Rumley A,
    4. Cherry L,
    5. Lowe GD,
    6. Sturrock R
    . Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 2005;109:171–6.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Heeneman S,
    2. Daemen MJ
    . Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol 2007;19:358–62.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Libby P
    . Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008;121 Suppl:S21–S31.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Gonzalez-Gay MA,
    2. Gonzalez-Juanatey C,
    3. Martin J
    . Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8–17.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. O’Leary DH,
    2. Polak JF
    . Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002;90:18L–21L.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Bots ML,
    2. Dijk JM,
    3. Oren A,
    4. Grobbee DE
    . Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 2002;20:2317–25.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Franklin SS,
    2. Khan SA,
    3. Wong ND,
    4. Larson MG,
    5. Levy D
    . Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999;100:354–60.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Mattace-Raso FU,
    2. van der Cammen TJ,
    3. Hofman A,
    4. van Popele NM,
    5. Bos ML,
    6. Schalekamp MA,
    7. et al.
    Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113:657–63.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Laurent S,
    2. Boutouyrie P
    . Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 2007;49:1202–6.
    OpenUrlFREE Full Text
  16. 16.↵
    1. Laurent S,
    2. Cockcroft J,
    3. Van Bortel L,
    4. Boutouyrie P,
    5. Giannattasio C,
    6. Hayoz D,
    7. et al.
    Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588–605.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Braun J,
    2. Davis J,
    3. Dougados M,
    4. Sieper J,
    5. van der Linden S,
    6. van der Heijde D
    . First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2006;65:316–20.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Van der Linden S,
    2. Valkenburg HA,
    3. Cats A
    . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Peters MJ,
    2. Vis M,
    3. van Halm VP,
    4. Wolbink GJ,
    5. Voskuyl AE,
    6. Lems WF,
    7. et al.
    Changes in lipid profile during infliximab treatment and corticosteroid therapy in rheumatoid arthritis. Ann Rheum Dis 2007;66:958–61.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Garrett S,
    2. Jenkinson T,
    3. Kennedy LG,
    4. Whitelock H,
    5. Gaisford P,
    6. Calin A
    . A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286–91.
    OpenUrlPubMed
  21. 21.↵
    1. Calin A,
    2. Garrett S,
    3. Whitelock H,
    4. Kennedy LG,
    5. O’Hea J,
    6. Mallorie P,
    7. et al.
    A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281–5.
    OpenUrlPubMed
  22. 22.↵
    1. Jenkinson TR,
    2. Mallorie PA,
    3. Whitelock HC,
    4. Kennedy LG,
    5. Garrett SL,
    6. Calin A
    . Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694–8.
    OpenUrlPubMed
  23. 23.↵
    1. Hollander M,
    2. Bots ML,
    3. Del Sol AI,
    4. Koudstaal PJ,
    5. Witteman JC,
    6. Grobbee DE,
    7. et al.
    Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 2002;105:2872–7.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Van Bortel LM,
    2. Balkestein EJ,
    3. van der Heijden-Spek JJ,
    4. Vanmolkot FH,
    5. Staessen JA,
    6. Kragten JA,
    7. et al.
    Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 2001;19:1037–44.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Van Bortel LM,
    2. Duprez D,
    3. Starmans-Kool MJ,
    4. Safar ME,
    5. Giannattasio C,
    6. Cockcroft J,
    7. et al.
    Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002;15:445–52.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Han C,
    2. Robinson DW Jr,
    3. Hackett MV,
    4. Paramore LC,
    5. Fraeman KH,
    6. Bala MV
    . Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167–72.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Mathieu S,
    2. Joly H,
    3. Baron G,
    4. Tournadre A,
    5. Dubost JJ,
    6. Ristori JM,
    7. et al.
    Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology 2008;47:1203–7.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Choe JY,
    2. Lee MY,
    3. Rheem I,
    4. Rhee MY,
    5. Park SH,
    6. Kim SK
    . No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine 2008;75:548–53.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Malesci D,
    2. Niglio A,
    3. Mennillo GA,
    4. Buono R,
    5. Valentini G,
    6. La MG
    . High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 2007;26:710–4.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Sari I,
    2. Okan T,
    3. Akar S,
    4. Cece H,
    5. Altay C,
    6. Secil M,
    7. et al.
    Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology 2006;45:283–6.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Sattar N,
    2. McCarey DW,
    3. Capell H,
    4. McInnes IB
    . Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957–63.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Gonzalez-Gay MA,
    2. Gonzalez-Juanatey C,
    3. Pineiro A,
    4. Garcia-Porrua C,
    5. Testa A,
    6. Llorca J
    . High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005;32:1219–23.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Roman MJ,
    2. Devereux RB,
    3. Schwartz JE,
    4. Lockshin MD,
    5. Paget SA,
    6. Davis A,
    7. et al.
    Arterial stiffness in chronic inflammatory diseases. Hypertension 2005;46:194–9.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Vlachopoulos C,
    2. Dima I,
    3. Aznaouridis K,
    4. Vasiliadou C,
    5. Ioakeimidis N,
    6. Aggeli C,
    7. et al.
    Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005;112:2193–200.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Wanders A,
    2. Landewe R,
    3. Dougados M,
    4. Mielants H,
    5. van der Linden S,
    6. van der Heijde D
    . Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? Ann Rheum Dis 2005;64:988–94.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Peters MJ,
    2. Symmons D,
    3. McCarey DW,
    4. Nurmohamed MT
    . Cardiovascular risk management in patients with rheumatoid arthritis and other inflammatory arthritis: A EULAR Task Force. Arthritis Rheum 2008;58:s421–s422.
    OpenUrl
  37. 37.↵
    1. Nichols WW,
    2. O’Rourke M
    . McDonald’s blood flow in arteries. Theoretical, experimental and clinical principles. 4th ed. London: Arnold; 1998:54–401.
  38. 38.↵
    1. Dart AM,
    2. Gatzka CD,
    3. Kingwell BA,
    4. Willson K,
    5. Cameron JD,
    6. Liang YL,
    7. et al.
    Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension 2006;47:785–90.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Johnson AG,
    2. Nguyen TV,
    3. Day RO
    . Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121:289–300.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section